News Today Logo

Posted 18 Mar 2024

Updated 28 Mar 2024

2 min read

  • SPI scheme addresses requirement for support to existing pharma clusters to improve productivity, quality and sustainability to make India a global leader in Pharma Sector.
    • SPI Tenure: FY 2021-2022 to FY 2025-26 (5 years)
  • SPI Scheme has three components
    • Assistance to Pharmaceutical Industry for Common Facilities (APICF)
    • Revamped Pharmaceutical Technology Upgradation Assistance Scheme (RPTUAS)
    • Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS)

 

APICF

PMPDS

  • Aim: Strengthen existing pharmaceutical clusters’ capacity for their sustained growth by creating common facilities.
  • Tenure: 5 years. 
  • Limit of incentive will be 70% of approved project cost or Rs 20 crore, whichever is less,
  • Eligible activities: R&D Labs; Testing Laboratory for Pharma Products; Effluent Treatment Plants; Logistic Centers; Training Centers.
  • Monitoring: Project Management Consultant (PMC), agency appointed by Department of Pharmaceuticals (DoP).
  • Benefits:
    • Improvement in quality standards and environmental regulatory compliance; 
    • Reduction in wastage of manufactured pharma products; 
    • Increased availability of trained personnel for pharma clusters; etc.
  • Aim: Facilitate growth and development of Pharmaceutical and Medical Devices Sectors through conducting studies, awareness programs, etc.
  • Tenure: 5 years.
  • Eligible activities: Database Creation of pharmaceutical and medical device sector, etc.
  • Monitoring: PMC.
  • Benefits: Bring awareness about Government policies and identifying problems/issues faced by industry.
  • Tags :
  • Pharmaceuticals Industry
  • SPI scheme
Watch News Today
Width resize handle
Height resize handle

Search Notes

Filter Notes

No notes yet

Create your first note to get started.

No notes found

Try adjusting your search criteria.

Subscribe for Premium Features